Sanz-Moreno, A., Palomeras, S., Pedersen, K., Morancho, B., Pascual, T., Galván, P., . . . Gonzalez-Suarez, E. (2021). RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer. Breast Cancer Res.
Chicago ZitierstilSanz-Moreno, Adrián, et al. "RANK Signaling Increases After Anti-HER2 Therapy Contributing to the Emergence of Resistance in HER2-positive Breast Cancer." Breast Cancer Res 2021.
MLA ZitierstilSanz-Moreno, Adrián, et al. "RANK Signaling Increases After Anti-HER2 Therapy Contributing to the Emergence of Resistance in HER2-positive Breast Cancer." Breast Cancer Res 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.